Devyser and Thermo Fisher Scientific collaborate to promote laboratory services to advance pharmaceutical research
Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote...
News | May 30, 2020
From June 1st to June 7th 2020 is World Haemochromatosis Week.
Hemochromatosis is characterised by an excess of iron in blood. Causes for the disease are mostly hereditary and the illness can be diagnosed by genetic testing. Hemochromatosis is often overlooked because its symptoms are generally non-specific and can be confused with other illnesses.
The excess iron deposited in a variety of organs can however lead to irreversible tissue damage, particularly in the liver and pancreas, which leads to serious diseases such as cirrhosis, diabetes, arthritis or hypogonadism.
Early diagnosis of the disease is thus crucial.
The single tube PCR reagent kit Devyser HFE allows a fast and specific detection of mutations in the HFE gene.
Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote...
Read More
Devyser and Thermo Fisher Scientific have agreed to expand commercial collaboration by including...
Read More
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Read More
Devyser has inaugurated its CLIA-certified laboratory in Atlanta, Georgia. The laboratory will...
Read More